...
首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit
【24h】

Off-Label Use of Dexmedetomidine for the Treatment of Delirium in the Intensive Care Unit

机译:Dexmedetomidine的Off标记使用用于治疗重症监护病房的谵妄

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Evaluate recent clinical studies involving the use of dexmedetomidine (DEX) infusion for the treatment of delirium in the intensive care unit (ICU).Methods: A literature search was conducted to identify peer-reviewed articles in MEDLINE (1966-June 2016) using the terms sedation, analgesic, dexmedetomidine, delirium, and critically ill adult patients.Results: Two studies in the ICU setting reported the potential benefits of DEX for managing agitation during weaning from mechanical ventilation. One pilot study and a clinical trial reported the use of DEX in the treatment of ICU delirium.Conclusion: Further studies are required to evaluate the use of DEX treatment in critically ill patients presenting with delirium.
机译:目的:评价近期临床研究,涉及使用Dexmedetomidine(Dex)输注在重症监护单元(ICU)中使用Dexmedetomidine(Dex)输注(ICU)。方法:进行文献搜索,以确定Medline的同行评审条款(2016年6月) 使用术语镇静剂,镇痛,右传嘌呤,谵妄和批判性成年患者。结果:ICU设定中的两项研究报告了DEX在机械通气中断奶过程中令人振动的潜在好处。 一项试验研究和临床试验报告使用DEX治疗ICU谵妄。结论:需要进一步的研究来评估DEX治疗在患有谵妄的重症病患者中的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号